Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1632 1677
This examiner grants 65% of resolved cases
David A. Montanari examines cases in Tech Center 1600 and Art Unit 1632, with a total of 771 resolved cases. His 64.7% allowance rate is the baseline for success, while the median days to allowance is 1399. This suggests that while a majority of cases eventually reach allowance, the process often requires a significant time commitment.
The most striking data point is the 49.0% interview lift. This is a high figure, indicating that interviews are associated with a much higher likelihood of allowance than the 64.7% baseline. For the 771 resolved cases, the interview has proven to be a transformative tool. Practitioners should prioritize interviews to navigate the 1399-day median pendency, as the 49.0% lift suggests that direct dialogue is an effective way to resolve the examiner's concerns.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18201904 | METHODS FOR PREPARING MAMMALIAN CELLS FOR PERFUSION CELL CULTURE | Non-Final OA | Genentech, Inc. |
| 18473637 | MODIFIED ORGANISMS FOR ETHYLENE, ETHANE, AND METHANE BIOGENESIS AND METHODS FOR USE THEREOF | Non-Final OA | Ohio State Innovation Foundation |
| 17917109 | TGFß THERAPY FOR OCULAR AND NEURODEGENERATIVE DISEASES | Non-Final OA | PRESIDENT AND FELLOWS OF HARVARD COLLEGE |
| 18190068 | Compositions and Methods for Adjuvanted Vaccines | Non-Final OA | Massachusetts Institute of Technology |
| 18731343 | NUTRIENT MEDIA FOR THE PRODUCTION OF SLAUGHTER-FREE MEAT | Non-Final OA | Upside Foods, Inc. |
| 17776563 | OPTIDICER CONSTRUCT FOR AGE-RELATED MACULAR DEGENERATION | Final Rejection | University of Utah Research Foundation |
| 18249661 | METHODS FOR GENERATING FORMATIVE PLURIPOTENT STEM CELLS COMPETENT FOR DIRECT PRIMORDIAL GERM CELL INDUCTION | Final Rejection | The Board of Regents of The University of Texas System |
| 18253903 | EXPRESSION TECHNOLOGY FOR ANTIBODY CONSTRUCTS | Non-Final OA | Novartis AG |
| 18494365 | CYTOPLASMIC INCOMPATIBILITY FACTORS AND METHODS FOR CONTROLLING ANTHROPODS | Non-Final OA | YALE UNIVERSITY |
| 18473619 | COLONIC ORGANOIDS AND METHODS OF MAKING AND USING SAME | Non-Final OA | Children's Hospital Medical Center |
| 17842530 | ADENO-ASSOCIATED VIRUS VIRIONS WITH VARIANT CAPSID AND METHODS OF USE THEREOF | Final Rejection | The Trustees of the University of Pennsylvania |
| 18552693 | Compositions For and Methods of Editing the Genome | Non-Final OA | DUKE UNIVERSITY |
| 18866750 | GENETICALLY ENGINEERED MUCOSAL-ASSOCIATED INVARIANT T (MAIT) CELLS FOR ADOPTIVE TRANSFER CELLTHERAPY | Non-Final OA | HADASIT MEDICAL RESEARCH SERVICES AND DEVELOPMENT LTD. |
| 18236218 | GENETICALLY MODIFIED NON-HUMAN ANIMALS AND METHODS OF USE THEREOF | Final Rejection | Institute for Research In Biomedicine (IRB) |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy